Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

LOSARTAN POTASSIUM

LOSARTAN POTASSIUM

Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LOSARTAN POTASSIUM is listed in Drugs@FDA under application 219859 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LOSARTAN POTASSIUM Form and strength TABLET;ORAL - 50MG Sponsor GRAVITI PHARMS Submission history Latest submission status date: 2025-09-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview LOSARTAN POTASSIUM is listed in Drugs@FDA under application 219859 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LOSARTAN POTASSIUM Form and strength TABLET;ORAL - 50MG Sponsor GRAVITI PHARMS Submission history Latest submission status date: 2025-09-19 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.